The findings revealed that Nrf2 plays an oncogenic role in the formation of renal cancer since the group with renal cancer had elevated Nrf2 levels, which were reversed to normal levels in the groups receiving canagliflozin treatment. The gene discussed is NFE2L2; the disease is renal carcinoma.